Featured Research

from universities, journals, and other organizations

Biology Researchers Map Gene For Age-Related Hearing Loss In Mice

Date:
February 26, 1998
Source:
University Of Cincinnati
Summary:
A team of scientists from the University of Cincinnati, the Jackson Laboratory in Bar Harbor, Maine and Northern Illinois University have mapped the first gene known to cause age-related hearing loss in mice.

Cincinnati -- A team of scientists from the University of Cincinnati, the Jackson Laboratory in Bar Harbor, Maine and Northern Illinois University have mapped the first gene known to cause age-related hearing loss in mice.

The researchers reported in the current issue of the journal Hearing Research that they used microsatellite DNA markers to map the age-related hearing loss (Ahl) gene to mouse Chromosome 10. Ahl appears be to a single gene, recessive trait.

The researchers worked with the C57BL/6J inbred strain of mice, the most commonly studied strain in age-related hearing loss research. Its abbreviated name is the B6 mouse.

Larry Erway, professor of biological sciences at the University of Cincinnati, said the mapping work involved traditional and time-consuming genetic crosses as well as the newer DNA microsatellite techniques.

"We started the genetic cross in 1991," said Erway. The mice were produced at the Jackson Laboratory and sent here. I reared the animals and aged them to two years of age."

Tissue samples demonstrated that the Ahl gene was on Chromosome 10, but the research team then did an additional three years of work to confirm their results. This part of the research involved back-crossing the wildtype or normal gene from another strain with normal hearing to the mice with hearing loss. This produced a genetically similar, or congenic, strain with normal hearing. The only difference was the replacement of the mutant Ahl gene with the gene for normal hearing. Because the new congenic strain had normal hearing, and the only difference between the two strains was a single stretch of Chromosome 10, that was further evidence of the location of the Ahl gene.

The researchers used two different techniques to document hearing loss in the mice. The first is called ABR for auditory- evoked brainstem response which measures the reception and transmission of nerve signals in the brain. As mice lose their hearing, it requires a louder audio signal to get a response. In addition, James Willott of Northern Illinois University examined the sensory ganglion cells associated with the inner ear or cochlea.

"When he looked at these cells within the cochlea of B6 mice, the cells begin to be lost by four to six months." said Erway. "We started picking up hearing loss by eight months. We carried them to a year and a half, and most of them had very significant hearing losses. They eventually become deaf in old age."

Most important, Willott found that the year-old congenic mice retained cell densities of a young, normally hearing B6 mouse.

Other genes which cause hearing loss have also been mapped. The only genes cloned so far are from the "shaker-1" mutant and Snell's "waltzer." These mice not only lose their hearing, they have a balance disorder which causes them to run in wild circles. Both the shaker and waltzer genes produce an abnormal form of the protein myosin, which causes degeneration of the hair cells in the cochlea and the vestibular canals the part of the inner ear responsible for balance.

Erway said the Ahl cannot be identical to the shaker or waltzer genes, because Ahl only causes hearing loss, not a balance disorder. However, it could be an allele (a different version) of one of two waltzer genes found on Chromosome 10.

One of the most important implications, according to Erway, is the potential identification of genes related to age-related hearing loss in humans. Mice and humans have very similar auditory systems, and there is a human condition (Usher's syndrome) very similar to the condition caused by the mouse "shaker" gene. Since more than half the human population suffers from hearing loss by the age of 80, the long-term goal is to identify the specific causes of age-related hearing loss in humans.


Story Source:

The above story is based on materials provided by University Of Cincinnati. Note: Materials may be edited for content and length.


Cite This Page:

University Of Cincinnati. "Biology Researchers Map Gene For Age-Related Hearing Loss In Mice." ScienceDaily. ScienceDaily, 26 February 1998. <www.sciencedaily.com/releases/1998/02/980226075033.htm>.
University Of Cincinnati. (1998, February 26). Biology Researchers Map Gene For Age-Related Hearing Loss In Mice. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/1998/02/980226075033.htm
University Of Cincinnati. "Biology Researchers Map Gene For Age-Related Hearing Loss In Mice." ScienceDaily. www.sciencedaily.com/releases/1998/02/980226075033.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins